Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial.
Rodondi N, Collet TH, Nanchen D, Locatelli I, Depairon M, Aujesky D, Bovet P, Cornuz J.
Arch Intern Med. 2012 Feb 27;172(4):344-52. Epub 2012 Jan 23.
Related citations
A randomized controlled trial of positive-affect induction to promote physical activity after percutaneous coronary intervention.
Peterson JC, Charlson ME, Hoffman Z, Wells MT, Wong SC, Hollenberg JP, Jobe JB, Boschert KA, Isen AM, Allegrante JP.
Arch Intern Med. 2012 Feb 27;172(4):329-36. Epub 2012 Jan 23.
Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials.
Uchino K, Hernandez AV.
Arch Intern Med. 2012 Mar 12;172(5):397-402. Epub 2012 Jan 9. Review.
Dabigatran: do we have sufficient data?: comment on "Dabigatran association with higher risk of acute coronary events".
Jacobs JM, Stessman J.
Arch Intern Med. 2012 Mar 12;172(5):403-4. Epub 2012 Jan 9. No abstract available.
Important data after drug approval: comment on "Dabigatran association with higher risk of acute coronary events".
Redberg RF.
Arch Intern Med. 2012 Mar 12;172(5):404. Epub 2012 Jan 9. No abstract available.
Coronary artery calcium scanning in primary prevention: a conversation with cardiology fellows.
Ridker PM.
Arch Intern Med. 2011 Dec 12;171(22):2051-2. No abstract available.
Being successful at prevention: making it easy to do the right thing: comment on "Improving care after myocardial infarction using a 2-year internet-delivered intervention".
Steinhubl SR, Bloom FJ Jr, Darer J.
Arch Intern Med. 2011 Nov 28;171(21):1917-9. No abstract available.
Improving care after myocardial infarction using a 2-year internet-delivered intervention: the Department of Veterans Affairs myocardial infarction-plus cluster-randomized trial.
Levine DA, Funkhouser EM, Houston TK, Gerald JK, Johnson-Roe N, Allison JJ, Richman J, Kiefe CI.
Arch Intern Med. 2011 Nov 28;171(21):1910-7.
Percutaneous coronary intervention for persistent occlusion of the infarct-related artery: an expanded view of the evidence.
Appleton D, Abbate A, Biondi-Zoccai G.
Arch Intern Med. 2011 Nov 28;171(21):1960-1; author reply 1961. No abstract available.
Prognostic impact of hospital readmissions after primary percutaneous coronary intervention.
Campo G, Saia F, Guastaroba P, Marchesini J, Varani E, Manari A, Ottani F, Tondi S, De Palma R, Marzocchi A.
Arch Intern Med. 2011 Nov 28;171(21):1948-9. No abstract available.
National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention.
Herrin J, Miller LE, Turkmani DF, Nsa W, Drye EE, Bernheim SM, Ling SM, Rapp MT, Han LF, Bratzler DW, Bradley EH, Nallamothu BK, Ting HH, Krumholz HM.
Arch Intern Med. 2011 Nov 28;171(21):1879-86.
Factors associated with 30-day readmission rates after percutaneous coronary intervention.
Khawaja FJ, Shah ND, Lennon RJ, Slusser JP, Alkatib AA, Rihal CS, Gersh BJ, Montori VM, Holmes DR, Bell MR, Curtis JP, Krumholz HM, Ting HH.
Arch Intern Med. 2012 Jan 23;172(2):112-7. Epub 2011 Nov 28.
Prediction is very hard, especially about the future: comment on "factors associated with 30-day readmission rates after percutaneous coronary intervention".
Hernandez AF, Granger CB.
Arch Intern Med. 2012 Jan 23;172(2):117-9. Epub 2011 Nov 28. No abstract available.
Reconsidering transfer for percutaneous coronary intervention strategy: time is of the essence.
Arch Intern Med. 2012 Jan 23;172(2):98-9. Epub 2011 Nov 28. No abstract available.
Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.
Miller AL, Wang Y, Curtis J, Masoudi FA, Buxton AE, Wang TY.
Arch Intern Med. 2012 Jan 9;172(1):64-7. Epub 2011 Nov 14. No abstract available.
Error occurred: cannot get document summary
Body weight in early and mid-adulthood in relation to subsequent coronary heart disease mortality: 80-year follow-up in the Harvard Alumni Study.
Gray L, Lee IM, Sesso HD, Batty GD.
Arch Intern Med. 2011 Oct 24;171(19):1768-70; discussion 1770. No abstract available.
QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey.
Zhang Y, Post WS, Dalal D, Blasco-Colmenares E, Tomaselli GF, Guallar E.
Arch Intern Med. 2011 Oct 24;171(19):1727-33.
Cardiovascular device technology and health care cost.
Dean LS.
Arch Intern Med. 2011 Oct 10;171(18):1689; author's reply 1689. No abstract available.
Defining "appropriateness": the devil is in the definition.
Arch Intern Med. 2011 Oct 10;171(18):1673-4. Review. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on